Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2010

View Archived Issues

TLR7 agonist AZD-8848 efficacious in rhinitis and asthma models

Improvements in depression and related disability seen with levomilnacipran

Epodure biopump sustains elevated Hb levels for 1 year

Serum SDF-1-alpha levels correlate with long-term prognosis of stroke

Fingolimod shows promise in mouse model of cerebral ischemia

Pharmacokinetic data disclosed on cinaciguat in hepatic and renal impairment

REDUCE and CombAT trial data presented on dutasteride in prostate cancer

AstraZeneca claims new DNA topoisomerase 4 inhibitors

New beta-secretase inhibitors described by AstraZeneca

Roche presents new tachykinin NK3 receptor antagonists

Banyu and Merck & Co. disclose new DGAT-1 inhibitors

StronBone bone graft substitute shows efficacy in vivo

FDA grants fast track status to AS-1413 for secondary AML

Kyowa Hakko Kirin and BLS enter licensing agreement for istradefylline

FDA to review Eisai's NDA for AcipHex ER 50-mg tablets

Phase III RADIANT-3 trial of everolimus meets primary endpoint

FDA extends review period for Abstral

Johns Hopkins receives MSCRF grant to study Q-Cells in demyelinating disease

Galiximab shows minimal activity in relapsed Hodgkin's lymphoma

Verona Pharma provides company update at annual general meeting

Ablynx and reMYND settle dispute relating to Nanobodies agreement

Phase IIb trial of PEG-Interferon lambda initiated in hepatitis C

Encouraging phase Ib/II data reported on AVI-4658 in DMD

PregLem reports phase III data on Esmya in uterine fibroids

FDA issues updated recommendations for LABAs

Grifols to begin clinical trial of new Alzheimer's disease therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...